Human Ccr4 and Caf1 Deadenylases Regulate Proliferation and Tumorigenicity of Human Gastric Cancer Cells via

Xiao-Hui Song1, Xiao-Yan Liao1, Xu-Ying Zheng1

  • 1State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China.

Cancers
|March 6, 2021
PubMed

Insights

Targeting RNA metabolism by inhibiting human Ccr4a/b (hCcr4a/b) and Caf1a/b (hCaf1a/b) deadenylases disrupts cancer cell proliferation and tumorigenicity, offering a novel cancer treatment strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • Cancer cells exhibit altered gene expression for survival and metastasis.
  • Global RNA metabolism is a potential target for cancer therapy.
  • The Ccr4-Not complex, including deadenylases, plays a role in gene regulation.

Purpose of the Study:

  • To investigate the role of human Ccr4a/b (hCcr4a/b) and Caf1a/b (hCaf1a/b) deadenylases in cancer cell proliferation.
  • To explore the impact of depleting these deadenylases on cancer cell growth and tumorigenicity.
  • To elucidate the mechanisms by which these deadenylases affect cell cycle progression and RNA processing.

Main Methods:

  • Establishment of stable cell lines with knockdown of hCcr4a/b or hCaf1a/b.
  • Transient knockdown experiments in various cancer cell lines.
  • Cell cycle analysis (G0/G1 and G2/M phase arrest).
  • Analysis of CDK-cyclin inhibitors and p21 mRNA levels.
  • Assessment of processing-body formation.

Main Results:

  • Depletion of hCcr4a/b or hCaf1a/b significantly inhibited cancer cell proliferation and tumorigenicity.
  • Knockdown of hCaf1a caused G2/M phase arrest, while hCaf1b or hCcr4a/b depletion led to G0/G1 arrest.
  • The deadenylases modulated CDK-cyclin inhibitor levels, with hCcr4a/b specifically targeting p21 mRNA.
  • Depletion of any of the four deadenylases impaired processing-body formation.

Conclusions:

  • Perturbing global RNA metabolism by targeting hCcr4a/b and hCaf1a/b deadenylases severely affects cancer cell proliferation.
  • These deadenylases represent potential therapeutic targets for novel cancer treatments.
  • Modulation of RNA metabolism offers a promising new avenue for cancer therapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K